Related Experiment Video
Updated: Nov 5, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Clinical features of 50 cases of 2019 novel coronavirus in Bandar Abbas, Iran
Hashem Jarineshin1, Fateme Saljoughi2, Hamideh Estabraghnia Babaki1
1Critical Care and Pain Management Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Insights
This study details the clinical features and outcomes of 50 coronavirus disease 2019 (COVID-19) patients. Key findings include common symptoms, laboratory abnormalities, and risk factors associated with severe illness and mortality in COVID-19.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Limited data exists on the clinical presentation and outcomes of coronavirus disease 2019 (COVID-19).
- Understanding COVID-19's impact is crucial for effective patient management and public health strategies.
Purpose of the Study:
- To describe the epidemiological, demographic, clinical, laboratory, and radiological features of COVID-19 patients.
- To compare outcomes between critically ill and non-critically ill COVID-19 patients.
- To identify factors associated with mortality in COVID-19.
Main Methods:
- A single-center retrospective observational study of 50 COVID-19 patients.
- Collection and analysis of epidemiological, demographic, clinical, laboratory, radiological, and treatment data.
- Comparison of outcomes between critically ill and non-critically ill patient groups.
Main Results:
- The average patient age was 48.8 years, with a male predominance. Common symptoms included dry cough, fever, and dyspnea. Chronic medical illnesses were present in 56% of patients.
- Frequent laboratory abnormalities included lymphopenia, neutrophilia, thrombocytopenia, elevated liver enzymes, creatinine, lactate dehydrogenase, ESR, and CRP. Chest CT scans often showed bilateral ground-glass opacities and consolidation.
- 10% of patients died, with mortality higher in men and those with chronic illnesses or requiring invasive mechanical ventilation. Blood oxygen saturation differed between survivors and non-survivors.
Conclusions:
- COVID-19 presents with a wide spectrum of signs and symptoms.
- Laboratory findings suggest potential cellular immune deficiency, myocardial, hepatic, and kidney injury associated with COVID-19.
- Further research is necessary to fully understand the pathogenesis of COVID-19.
Abstract:
Background: There is sparse information to describe the clinical features and outcomes of patients infected with coronavirus disease 2019 (COVID-19). Methods: In a single-center retrospective observational study, 50 patients infected with COVID-19 were studied. Epidemiological, demographic, clinical, laboratory, radiological, and treatment data were collected and analyzed. Outcomes of critically ill patients and noncritically ill patients were compared. Results: The mean age of the patients was 48.8 years, with male predominance. Dry cough, fever, and dyspnea were the most complaining symptoms on admission. Chronic medical illnesses before admission were present in 56% of the patients. The most common laboratory abnormalities were lymphopenia, neutrophilia, thrombocytopenia, increased aspartate aminotransferase, high serum creatinine level, elevated lactate dehydrogenase, and increasing ESR and CRP levels. Bilateral mixed ground-glass opacity and consolidation were observed in chest CT scan of most patients. Some patients required supplemental oxygen and some needed invasive mechanical ventilation. Blood oxygen saturation was different between survivors and nonsurvivors. 10% of patients died, of whom 60% were men. 40% of dead cases had chronic medical illnesses; 60% underwent invasive mechanical ventilation. Conclusion: Among the patients diagnosed with COVID-19 infection, the frequent clinical presentation was with a wide range of signs and symptoms. The laboratory changes suggest that COVID-19 infection may be related to cellular immune deficiency, myocardial, hepatic, and kidney injury. Additional research is needed to elucidate COVID-19 pathogenesis.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pericarditis II: Clinical Features and Diagnostic Tests

